Kocharian Sh M, Chukanova T I, Sukhodolets V V
Genetika. 1977;13(10):1821-30.
Independently obtained mutations (apt) of resistance to DAP (2,6-diaminopurine) and MP (6-methylpurine), that affect adenine phosphoribosyltransferase (APRT) in Escherichia coli, are different in their effect on the conversion of several substrates of APRT, such as DAP, MP, MAP (6-methylaminopurine) and adenine, to their nucleotide derivatives. Most of mutants were resistant to DAP and MP, unable to utilize MAP (as purine source) and differed in their ability to uptake adenine from the medium. Among the mutants capable to utilize adenine the following types are found: (1) resistant to DAP and MP, but capable of utilizing MAP, and (2) resistant to DAP, capable of utilizing MAP, but sensitive to MP. The gene apt encoding APRT is located between genes proC and purE; the frequency of cotransduction between proC and several apt mutations is found to be 1.7--2% and purE-apt--to be 5--10.8%. Mutations apt block up the ability of purine-dependent (pur) bacteria lacking purine nucleoside phosphorylase (pup) to use purine ribonucleosides as purine sources. The degree of that blocking depends on the ability of apt mutants to convert adenine to AMP via APRT. These observations confirm our previous data, that the ability of pur pup mutants to use purine ribonucleosides depends on the activity of APRT.
独立获得的对二氨基嘌呤(DAP)和6-甲基嘌呤(MP)具有抗性的突变(apt)会影响大肠杆菌中的腺嘌呤磷酸核糖转移酶(APRT),这些突变对APRT的几种底物(如DAP、MP、6-甲基氨基嘌呤(MAP)和腺嘌呤)向其核苷酸衍生物的转化作用不同。大多数突变体对DAP和MP具有抗性,无法利用MAP(作为嘌呤来源),并且在从培养基中摄取腺嘌呤的能力方面存在差异。在能够利用腺嘌呤的突变体中,发现了以下几种类型:(1)对DAP和MP具有抗性,但能够利用MAP;(2)对DAP具有抗性,能够利用MAP,但对MP敏感。编码APRT的基因apt位于proC和purE基因之间;发现proC与几个apt突变之间的共转导频率为1.7% - 2%,purE与apt之间的共转导频率为5% - 10.8%。apt突变会阻碍缺乏嘌呤核苷磷酸化酶(pup)的嘌呤依赖性(pur)细菌利用嘌呤核糖核苷作为嘌呤来源的能力。这种阻碍的程度取决于apt突变体通过APRT将腺嘌呤转化为AMP的能力。这些观察结果证实了我们之前的数据,即pur pup突变体利用嘌呤核糖核苷的能力取决于APRT的活性。